IFIH1 and interstitial lung disease: Compared to classical anti-MDA5 positive DM, MIP-C had a lower incidence of ILD (41%) but more common proximal myopathy.[7] The authors did not address whether a potential reason for the lower incidence of ILD could have been the ethnic makeup of the patients studied – a possibly relevant aspect considering that the rates of ILD in Caucasian patients are lower (38%–73%) than those in Asian patients (82%–100%).[8] The lower mortality rate of MIP-C as compared to anti-MDA5 positive DM might also been possibly associates with demographics, although this was not investigated.